BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24495259)

  • 1. Review of findings in prophylactic gynaecological specimens in Lynch syndrome with literature review and recommendations for grossing.
    Downes MR; Allo G; McCluggage WG; Sy K; Ferguson SE; Aronson M; Pollett A; Gallinger S; Bilbily E; Shaw P; Clarke BA
    Histopathology; 2014 Aug; 65(2):228-39. PubMed ID: 24495259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic Risk-reducing Hysterectomies and Bilateral Salpingo-oophorectomies in Patients With Lynch Syndrome: A Clinicopathologic Study of 29 Cases and Review of the Literature.
    Fedda FA; Euscher ED; Ramalingam P; Malpica A
    Int J Gynecol Pathol; 2020 Jul; 39(4):313-320. PubMed ID: 31851061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome.
    Schmeler KM; Lynch HT; Chen LM; Munsell MF; Soliman PT; Clark MB; Daniels MS; White KG; Boyd-Rogers SG; Conrad PG; Yang KY; Rubin MM; Sun CC; Slomovitz BM; Gershenson DM; Lu KH
    N Engl J Med; 2006 Jan; 354(3):261-9. PubMed ID: 16421367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gynecologic cancer prevention in Lynch syndrome/hereditary nonpolyposis colorectal cancer families.
    Chen LM; Yang KY; Little SE; Cheung MK; Caughey AB
    Obstet Gynecol; 2007 Jul; 110(1):18-25. PubMed ID: 17601891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathologic Findings in Prophylactic and Nonprophylactic Hysterectomy Specimens of Patients With Lynch Syndrome.
    Bartosch C; Pires-Luís AS; Meireles C; Baptista M; Gouveia A; Pinto C; Shannon KM; Jerónimo C; Teixeira MR; Lopes JM; Oliva E
    Am J Surg Pathol; 2016 Sep; 40(9):1177-91. PubMed ID: 27340747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-operative evaluation of prophylactic hysterectomy and salpingo-oophorectomy specimens in hereditary gynaecological cancer syndromes.
    Wong S; Ratner E; Buza N
    Histopathology; 2018 Jul; 73(1):109-123. PubMed ID: 29484698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histologic evaluation of prophylactic hysterectomy and oophorectomy in Lynch syndrome.
    Karamurzin Y; Soslow RA; Garg K
    Am J Surg Pathol; 2013 Apr; 37(4):579-85. PubMed ID: 23426126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk-reducing surgery in women at hereditary risk of gynaecological cancer].
    Zikán M
    Ceska Gynekol; 2011 Jun; 76(3):216-21. PubMed ID: 21838153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary peritoneal cancer in Lynch syndrome: a clinical-pathologic report of a case and analysis of the literature.
    Ghezzi F; Uccella S; Cromi A; Bogani G; Donadello N; Riva C
    Int J Gynecol Pathol; 2013 Mar; 32(2):163-6. PubMed ID: 23370650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prophylactic hysterectomy in Lynch syndrome: Feasibility and outcomes].
    Pacelli J; Gosset M; Rossi L; Ngo C; Delomenie M; Nos C; Lécuru F; Bats AS
    Gynecol Obstet Fertil Senol; 2019 Jun; 47(6):497-503. PubMed ID: 31003015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
    Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic oophorectomy in women at increased cancer risk.
    Domchek SM; Rebbeck TR
    Curr Opin Obstet Gynecol; 2007 Feb; 19(1):27-30. PubMed ID: 17218848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of an endometrioid cancer lymph node metastasis without primary tumor in a context of Lynch syndrome.
    Koual M; Benoit L; Pacelli J; Lefrère Belda MA; Azaïs H; Bats AS
    J Gynecol Obstet Hum Reprod; 2021 Mar; 50(3):102060. PubMed ID: 33421625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic Gynecologic Specimens from Hereditary Cancer Carriers.
    Shaw PA; Clarke BA
    Surg Pathol Clin; 2016 Jun; 9(2):307-28. PubMed ID: 27241111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of occult gynecologic malignancy at the time of risk reducing and nonprophylactic surgery in patients with Lynch syndrome.
    Lachiewicz MP; Kravochuck SE; O'Malley MM; Heald B; Church JM; Kalady MF; Drake RD
    Gynecol Oncol; 2014 Feb; 132(2):434-7. PubMed ID: 24211399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prophylactic surgery in common hereditary cancer syndromes].
    Noguès C; Mouret-Fourme E
    Bull Acad Natl Med; 2012 Oct; 196(7):1237-45. PubMed ID: 23815011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Indications for prophylactic hysterectomy].
    Garabedian C; Lejeune S; Merlot B; Kerdraon O; Boulanger L; Collinet P
    Gynecol Obstet Fertil; 2013 Oct; 41(10):620-3. PubMed ID: 24120286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of risk-reducing gynaecological surgery in premenopausal women at high risk of endometrial and ovarian cancer due to Lynch syndrome.
    Moldovan R; Keating S; Clancy T
    Fam Cancer; 2015 Mar; 14(1):51-60. PubMed ID: 25342222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are women with endocervical adenocarcinoma at risk for lynch syndrome? Evaluation of 101 cases including unusual subtypes and lower uterine segment tumors.
    Mills AM; Liou S; Kong CS; Longacre TA
    Int J Gynecol Pathol; 2012 Sep; 31(5):463-9. PubMed ID: 22833088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.